Chen, Y. Y.; Liang,H. Q.; Liu, M. T.; Huang, W.; Yi, P. F.; Yuan, S. Q.; Mei, L. C.; Hu, Y.; H.; Cao, Y. Y.; Hao, G. F.; Q.*; Yang, G. F.* Catalase Inhibitors with Dual Pro-Oxidant Effect as New Therapeutic Agents in Castration-Resistant Prostate Cancer. Adv. Therap. 2020, 2000164.
Release Time:2026-06-15
Hits:
- Date:
- 2026-06-15
- Title of Paper:
- Chen, Y. Y.; Liang,H. Q.; Liu, M. T.; Huang, W.; Yi, P. F.; Yuan, S. Q.; Mei, L. C.; Hu, Y.; H.; Cao, Y. Y.; Hao, G. F.; Q.*; Yang, G. F.* Catalase Inhibitors with Dual Pro-Oxidant Effect as New Therapeutic Agents in Castration-Resistant Prostate Cancer. Adv. Therap. 2020, 2000164.
- Translation or Not:
- No
- Prev One:Zhuo, L. S.; Wang, M. S.; Yang, J. F.; Xu, H. C.; Huang, W.; Shang, L. Q.*; Yang, G.F.* Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology. Topics Curr. Chem. 2021, 379, 23. (IF2020 = 9.060)
- Next One:Xin, M. H.;* Sun, J. J.; Huang, W.;* Tang, F.; Liu, Z. Y.; Jin, Q.; Wang, J.Design and synthesis of novel phpyridazinone derivatives as potent poly(ADP-ribose)-polymerase (PARP) inhibitors. Future Med. Chem. 2020, 12, 1691-1707. (IF2020 = 3.808，二区)